City Therapeutics, Inc. (CTY)
City Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

City Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec '25 Dec '24
Debt / Equity Ratio
-0.43-0.79-0.76
Debt / EBITDA Ratio
-0.66-1.13-0.76
Debt / FCF Ratio
-0.71-1.53-0.93
Net Debt / Equity Ratio
0.850.543.55
Net Debt / EBITDA Ratio
1.300.773.56
Net Debt / FCF Ratio
1.391.034.37
Quick Ratio
2.703.006.18
Return on Equity (ROE)
66.56%69.11%94.60%
Return on Assets (ROA)
--39.06%-19.15%
Return on Invested Capital (ROIC)
--50.71%-23.34%
Return on Capital Employed (ROCE)
136.35%-54.11%-23.90%